Juan Manuel Viveros-Paredes

Dr. Juan Manuel Viveros-Paredes

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2019 in Journal of Medicinal Food
Verified
Journal Article
Closed access
DADalia Samanta Aguilar-Ávila
Dalia Samanta Aguilar-Ávila
MSMario Eduardo Flores soto
Mario Eduardo Flores soto
CTCarolina Tapia-Vázquez
Carolina Tapia-Vázquez
OPOmar Alonso Pastor-Zarandona
Omar Alonso Pastor-Zarandona
RRRocio Ivette Lopez Roa
Rocio Ivette Lopez Roa
JVJuan Manuel Viveros-Paredes
Juan Manuel Viveros-Paredes
Neuropathic pain (NP) is associated with chronic hyperglycemia and emotional disorders such as depression in diabetic patients, complicating the course of treatment. Drugs currently used to treat NP have undesirable side effects, so research on other natural sources has been required. β -caryophyllene (BCP), a natural sesquiterpene found in some food condiments and considered an agonist to cannabinoid receptor type 2, could have potential therapeutic effects to treat conditions such as NP and emotional disorders. For this reason, we assessed whether BCP modulates nociception, anxiety, and depressive-like behavior in streptozotocin (STZ)-induced experimental diabetic BALB/c female mice. BCP was orally chronic administrated (10 mg/kg/60 μ L). Pain developed with STZ was evaluated with von Frey filament test, SMALGO ® , and hot plate test. Anxiety and depression-like behavior were assessed by marbles test, forced swim test, and tail suspension test. BCP significantly reduced glycemia in experimental diabetic mice. The pain was also mitigated by BCP administration. Depression-like behavior assessed with tail suspension test was attenuated with orally chronic BCP administration. Substance P and cytokines such as interleukin-1 β (IL-1 β ), tumor necrosis factor α (TNF-α), and interleukin-6 (IL-6) were also attenuated with BCP administration. NP was positively correlated with substance P and IL-6 and IL-1 β release. Our data using an orally chronic BCP administration in the STZ challenged mice to suggest that glycemia, diabetes-related NP, and depressive-like behavior could be prevented/reduced by dietary BCP.

11 July 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Paola Trinidad Villalobos  GutiérrezPaola Trinidad Villalobos Gutiérrez
Paola Trinidad Villalobos Gutiérrez
José Luis Muñoz-CarrilloJosé Luis Muñoz-Carrillo
José Luis Muñoz-Carrillo
CSCuauhtemoc Sandoval Salazar
Cuauhtemoc Sandoval Salazar
JVJuan Manuel Viveros-Paredes
Juan Manuel Viveros-Paredes
Oscar Gutiérrez-CoronadoOscar Gutiérrez-Coronado
Oscar Gutiérrez-Coronado
Currently, there are many studies on the application of nanotechnology in therapy. Metallic nanoparticles are promising nanomaterials in cancer therapy; however, functionalization of these nanoparticles with biomolecules has become relevant as their effect on cancer cells is considerably increased by photothermal and photodynamic therapies, drug nanocarriers, and specificity by antibodies, resulting in new therapies that are more specific against different types of cancer. This review describes studies on the effect of functionalized palladium, gold, silver and platinum nanoparticles in the treatment of cancer, these nanoparticles themselves show an anticancer effect. This effect is further enhanced when the NPs are functionalized with either antibodies, DNA, RNA, peptides, proteins, or folic acid and other molecules. These NPs can penetrate the cell and accumulate in the tumor tissue, resulting in a cytotoxic effect through the generation of ROS, the induction of apoptosis, cell cycle arrest, DNA fragmentation, and a photothermal effect. NP-based therapy is a new strategy that can be used synergistically with chemotherapy and radiotherapy to achieve more effective therapies and reduce side effects.

25 October 2017 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Open access
IRInés Reynoso-Moreno
Inés Reynoso-Moreno
INIsrael Najar-Guerrero
Israel Najar-Guerrero
NENoé Escareño
Noé Escareño
MSMario Eduardo Flores soto
Mario Eduardo Flores soto
Jürg GertschJürg Gertsch
Jürg Gertsch
JVJuan Manuel Viveros-Paredes
Juan Manuel Viveros-Paredes
Guineensine is a dietary N-isobutylamide widely present in black and long pepper (Piper nigrum and Piper longum) previously shown to inhibit cellular endocannabinoid uptake. Given the role of endocannabinoids in inflammation and pain reduction, here we evaluated guineensine in mouse models of acute and inflammatory pain and endotoxemia. Significant dose-dependent anti-inflammatory effects (95.6 ± 3.1% inhibition of inflammatory pain at 2.5 mg/kg ip and 50.0 ± 15.9% inhibition of edema formation at 5 mg/kg ip) and acute analgesia (66.1 ± 28.1% inhibition at 5.0 mg/kg ip) were observed. Moreover, guineensine inhibited proinflammatory cytokine production in endotoxemia. Intriguingly, guineensine and LPS independently induced catalepsy, but in combination this effect was abolished. Both hypothermia and analgesia were blocked by the CB1 receptor inverse agonist rimonabant, but the pronounced hypolocomotion was CB1 receptor-independent. A subsequent screen of 45 CNS-related receptors, ion channels, and transporters revealed apparent interactions of guineensine with the dopamine transporter DAT, 5HT2A, and sigma receptors, uncovering its prospective polypharmacology. The described potent pharmacological effects of guineensine might relate to the reported anti-inflammatory effects of pepper.

1 January 2021 in Neuroscience Letters
Verified
Journal Article
Closed access
MFM.E. Flores-Soto
M.E. Flores-Soto
JCJ.A. Corona-Angeles
J.A. Corona-Angeles
ATA.R. Tejeda-Martinez
A.R. Tejeda-Martinez
PFP.A. Flores-Guzman
P.A. Flores-Guzman
ILI. Luna-Mujica
I. Luna-Mujica
JVJuan Manuel Viveros-Paredes
Juan Manuel Viveros-Paredes

27 February 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
ASAlma Marina Sánchez Sánchez
Alma Marina Sánchez Sánchez
AZAdelaida Sara Zepeda
Adelaida Sara Zepeda
LQLucrecia Carrera Quintanar
Lucrecia Carrera Quintanar
JVJuan Manuel Viveros-Paredes
Juan Manuel Viveros-Paredes
NFNoel Noé Franco-Arroyo
Noel Noé Franco-Arroyo
RRRocio Ivette Lopez Roa
Rocio Ivette Lopez Roa
Obesity generates a chronic low-grade inflammatory state which promotes oxidative stress and triggers comorbidities. Alliin is the main organosulfur compound in garlic and has been shown to induce a decrease in the expression of proinflammatory cytokines; its systemic effect on metabolic parameters and adipose tissue is not yet known, however. After nine weeks of HFD and with obesity established in C57BL/6 mice, we observed that a daily treatment with alliin for 3.5 weeks (15 mg/kg) did not affect body weight, but significantly improved insulin sensitivity and glucose tolerance, both evaluated through a blood glucose monitoring system. Once alliin treatment was completed, serum, adipose tissue, and organs of interest related to metabolism were removed for further analysis. We observed that alliin significantly decreased the size of adipocytes from epididymal adipose tissue, evaluated via microscopy. A decrease in gene expression and serum protein levels of the adipocytokines leptin and resistin, as well as decreased serum IL-6 concentration, were detected by qRT-PCR and ELISA, respectively. It did not, however, affect mRNA expression of antioxidant enzymes in the liver. Taken altogether, these results indicate that treatment with alliin reduces metaflammation markers in DIO mice and improves some metabolic parameters without affecting others.

1 May 2020 in Journal of Medicinal Food
Verified
Journal Article
Closed access
PCPaulina Chávez-Hurtado
Paulina Chávez-Hurtado
RGRocío E. González-Castañeda
Rocío E. González-Castañeda
CBCarlos Beas-Zarate
Carlos Beas-Zarate
MFMario E. Flores-Soto
Mario E. Flores-Soto
JVJuan Manuel Viveros-Paredes
Juan Manuel Viveros-Paredes
Aging is associated with detrimental cellular and cognitive changes, making it an important public health concern; yet, many of these changes may be influenced by nutritional interventions. The natural sesquiterpene β-caryophyllene (BCP) has anti-inflammatory and antioxidant effects that are mediated by cannabinoid type-2 receptor activation, and these actions promote neuroprotection in different animal models that involve a cognitive damage. Consequently, whether chronic administration of BCP might prevent the age-related cellular and cognitive damage in a model of aging induced by chronic d-galactose (GAL) consumption was assessed here. Male BALB/c mice were administered BCP (10 mg/kg, oral), GAL (300 mg/kg, intraperitoneal), or GAL+BCP, and long-term memory and cognitive flexibility were evaluated in the normal and the reverse phases of Morris water maze test. In addition, immunohistochemistry was performed on prefrontal and hippocampal brain slices to detect glial acidic fibrillary protein and DNA oxidation. Although GAL administration reduced cognitive flexibility (P = .0308), this functional damage was not reversed by administering BCP. However, GAL administration also elevated the total number of astrocytes and their interactions in the hippocampus, and increasing DNA oxidation in the prefrontal cortex. BCP administration impeded the rise in the total number of astrocytes (P = .0286) and the DNA oxidation (P = .0286) in mice that received GAL. Hence, although BCP did not improve cognitive flexibility, it did produce a neuroprotective effect at the molecular and cellular level in the GAL model of aging.